Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma

NCT00604578 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Asthma
Airway Inflammation
Airflow Obstruction
Airway Hyperactivity

Interventions

DRUG: Pioglitazone Hydrochloride

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)